Restructuring Capital Associates Lp increased its stake in Kohls Corp (KSS) by 18.52% based on its latest 2018Q1 regulatory filing with the SEC. Restructuring Capital Associates Lp bought 25,000 shares as the company’s stock declined 2.71% with the market. The hedge fund held 160,000 shares of the department and specialty retail stores company at the end of 2018Q1, valued at $10.48M, up from 135,000 at the end of the previous reported quarter. Restructuring Capital Associates Lp who had been investing in Kohls Corp for a number of months, seems to be bullish on the $12.71B market cap company. The stock increased 0.93% or $0.7 during the last trading session, reaching $76.05. About 827,027 shares traded. Kohl's Corporation (NYSE:KSS) has risen 67.94% since June 20, 2017 and is uptrending. It has outperformed by 55.37% the S&P500. Some Historical KSS News: 13/03/2018 – KOHLS CORP KSS.N : CREDIT SUISSE INITIATES WITH OUTPERFORM, $72 TARGET PRICE; 16/03/2018 – Moody’s Affirms Eight and Downgrades One Class of LBCMT 2007-C3; 04/05/2018 – Celebrate Kohl’s Family Day and Kohl’s Captivation Station at Summerfest 2018; 16/04/2018 – Kohl’s Corporation Announces Increase in the Amount of Notes and Debentures to be Accepted in its Cash Tender Offer; 15/05/2018 – DEEP ECO: Kohl’s May Benefit, Industry Sales Rise This Quarter; 27/03/2018 – “Mad Money” host Jim Cramer sits down with Kevin Mansell, the outgoing chairman, president and CEO of Kohl’s, to discuss the retailer’s partnership with Amazon and the latest quarter; 02/04/2018 – Kohl’s Closes Below 50-Day Moving Average: Technicals; 22/05/2018 – KOHLS CORP KSS.N SEES FY 2018 SHR $4.86 TO $5.31 INCLUDING ITEMS; 16/04/2018 – Kohl’s Demonstrates Positive Social Impact in 2017 CSR Report; 21/04/2018 – DJ Kohl’s Corporation, Inst Holders, 1Q 2018 (KSS)
P-R Herzig & Co increased its stake in Amgen Inc (AMGN) by 23.49% based on its latest 2018Q1 regulatory filing with the SEC. P-R Herzig & Co bought 2,505 shares as the company’s stock declined 5.44% with the market. The institutional investor held 13,170 shares of the biological products (no diagnostic substances) company at the end of 2018Q1, valued at $2.25M, up from 10,665 at the end of the previous reported quarter. P-R Herzig & Co who had been investing in Amgen Inc for a number of months, seems to be bullish on the $123.54 billion market cap company. The stock increased 0.27% or $0.505 during the last trading session, reaching $186.695. About 751,729 shares traded. Amgen Inc. (NASDAQ:AMGN) has risen 14.68% since June 20, 2017 and is uptrending. It has outperformed by 2.11% the S&P500. Some Historical AMGN News: 17/04/2018 – New — Blockbuster ambitions: Amgen/Novartis team lines up more promising PhIII erenumab data for some of the toughest migraine patients $AMGN $NVS $LLY; 24/04/2018 – EXPRESS SCRIPTS ESRX.O SAYS PRESSING AMGEN INC AMGN.O , RIVALS TO CHANGE DYNAMIC OF HIGH LIST PRICES, DEEP REBATES ON NEW MIGRAINE MEDICINES; 27/04/2018 – Amgen Receives Positive CHMP Opinion to Expand Use of Prolia(R) (denosumab) to Patients With Glucocorticoid-Induced Osteoporosis; 15/05/2018 – Amgen Closes Below 50-Day Moving Average: Technicals; 26/04/2018 – ABBVIE INC – QTRLY GLOBAL HUMIRA SALES $4.71 BLN, UP 14.4 PCT ON REPORTED BASIS; 01/05/2018 – Sanofi/Regeneron’s one-two punch on PCSK9 price and health data wins a key convert as Express Scripts creates exclusive formulary deal $REGN $SNY $AMGN $ESRX; 19/05/2018 – Egan Bernal Becomes First Colombian Amgen Tour of California Champion; Countryman Fernando Gaviria Sweeps Sprint Stages at Sacramento Race Conclusion; 25/05/2018 – FDA CONFIRMS ORPHAN DRUG STATUS FOR AMGEN’S ROMIPLOSTIM; 17/05/2018 – AMGEN AMGN.O SETS LIST PRICE FOR AIMOVIG MIGRAINE DRUG AT $6,900 PER YEAR, OR $575 PER MONTH; 23/03/2018 – AMGEN INC – RECOMMENDED FOR APPROVAL FOR SAME INDICATIONS AS HERCEPTIN
P-R Herzig & Co, which manages about $134.68M and $49.74M US Long portfolio, decreased its stake in General Electric Co (NYSE:GE) by 29,300 shares to 13,100 shares, valued at $177,000 in 2018Q1, according to the filing.
Since January 16, 2018, it had 0 buys, and 6 selling transactions for $1.65 million activity.
More important recent Amgen Inc. (NASDAQ:AMGN) news were published by: Seekingalpha.com which released: “Amgen Has Me Worried Therefore Selling Calls” on May 31, 2018, also Streetinsider.com published article titled: “Amgen (AMGN) Granted EC Full Marketing Approval to Add Overall Survival Data To BLINCYTO (blinatumomab) Label”, 247Wallst.com published: “Amgen Wins Another FDA Approval” on May 22, 2018. More interesting news about Amgen Inc. (NASDAQ:AMGN) was released by: Seekingalpha.com and their article: “EC grants full approval for Amgen’s Blincyto” with publication date: June 19, 2018.
Investors sentiment decreased to 0.88 in Q1 2018. Its down 0.34, from 1.22 in 2017Q4. It dived, as 67 investors sold AMGN shares while 557 reduced holdings. 114 funds opened positions while 435 raised stakes. 502.72 million shares or 8.88% less from 551.71 million shares in 2017Q4 were reported. Veritas Llp invested in 20 shares or 0% of the stock. Ontario – Canada-based Tdam Usa Inc has invested 0.13% in Amgen Inc. (NASDAQ:AMGN). State Of Tennessee Treasury Department stated it has 0.37% in Amgen Inc. (NASDAQ:AMGN). Birinyi Assoc Inc invested in 7,927 shares or 0.55% of the stock. Quantbot Ltd Partnership stated it has 0.37% in Amgen Inc. (NASDAQ:AMGN). Illinois-based Chesley Taft And Limited Liability has invested 0.34% in Amgen Inc. (NASDAQ:AMGN). Convergence Investment Ltd Llc accumulated 1.22% or 54,954 shares. Logan Management holds 0.55% or 45,682 shares. Credit Agricole S A invested 0.02% of its portfolio in Amgen Inc. (NASDAQ:AMGN). Compton Cap Mngmt Ri reported 8,718 shares stake. Qci Asset Inc Ny has invested 1.71% in Amgen Inc. (NASDAQ:AMGN). Sumitomo Mitsui Asset Mngmt Com holds 46,790 shares. Opus Management holds 0.93% or 29,600 shares. Verition Fund Management Lc owns 17,644 shares. Regal Invest Limited Liability Corp, a Michigan-based fund reported 1,944 shares.
Among 25 analysts covering Amgen Inc. (NASDAQ:AMGN), 11 have Buy rating, 0 Sell and 14 Hold. Therefore 44% are positive. Amgen Inc. had 89 analyst reports since August 3, 2015 according to SRatingsIntel. The company was maintained on Tuesday, October 3 by Cowen & Co. The firm earned “Hold” rating on Monday, February 5 by Atlantic Securities. Barclays Capital maintained the shares of AMGN in report on Friday, October 13 with “Equal-Weight” rating. The company was initiated on Friday, December 18 by Atlantic Securities. The rating was maintained by Oppenheimer with “Buy” on Monday, June 26. The stock of Amgen Inc. (NASDAQ:AMGN) has “Market Perform” rating given on Tuesday, September 1 by Raymond James. The stock of Amgen Inc. (NASDAQ:AMGN) has “Outperform” rating given on Tuesday, December 13 by Oppenheimer. Jefferies maintained it with “Buy” rating and $200.0 target in Sunday, August 27 report. As per Wednesday, November 1, the company rating was downgraded by Argus Research. The firm has “Hold” rating given on Monday, January 22 by RBC Capital Markets.
Among 30 analysts covering Kohl’s Corporation (NYSE:KSS), 13 have Buy rating, 3 Sell and 14 Hold. Therefore 43% are positive. Kohl’s Corporation had 119 analyst reports since August 6, 2015 according to SRatingsIntel. Robert W. Baird maintained the shares of KSS in report on Monday, October 30 with “Hold” rating. The stock of Kohl's Corporation (NYSE:KSS) earned “Hold” rating by Cowen & Co on Thursday, August 10. The rating was maintained by UBS with “Neutral” on Friday, May 12. The rating was initiated by Northcoast on Friday, December 8 with “Neutral”. The company was maintained on Tuesday, January 9 by Jefferies. The rating was upgraded by JP Morgan on Friday, January 12 to “Overweight”. The firm has “Outperform” rating given on Monday, October 9 by Telsey Advisory Group. On Thursday, June 7 the stock rating was maintained by Deutsche Bank with “Hold”. The stock of Kohl's Corporation (NYSE:KSS) has “Buy” rating given on Friday, May 13 by Stifel Nicolaus. Gordon Haskett initiated it with “Reduce” rating and $35 target in Tuesday, May 9 report.
Investors sentiment decreased to 0.84 in Q1 2018. Its down 0.22, from 1.06 in 2017Q4. It fall, as 54 investors sold KSS shares while 193 reduced holdings. 75 funds opened positions while 133 raised stakes. 167.86 million shares or 1.29% more from 165.73 million shares in 2017Q4 were reported. Thompson Inv Management Incorporated, Wisconsin-based fund reported 72,369 shares. Employees Retirement Association Of Colorado reported 0.01% stake. The Ontario – Canada-based Cumberland Prns has invested 1.39% in Kohl's Corporation (NYSE:KSS). Captrust Financial owns 24,442 shares for 0.09% of their portfolio. Nj State Employees Deferred Compensation Plan reported 13,000 shares. 50 were reported by Sun Life. Clarivest Asset Mngmt Ltd Liability holds 0.54% or 474,486 shares. Vident Invest Advisory Limited Co holds 0.17% of its portfolio in Kohl's Corporation (NYSE:KSS) for 67,591 shares. Sentinel Lba has invested 0.87% in Kohl's Corporation (NYSE:KSS). Lifeplan Financial accumulated 0.09% or 2,269 shares. Schwab Charles Invest has invested 0.06% in Kohl's Corporation (NYSE:KSS). Advisory Svcs Lc reported 5,645 shares stake. Benjamin F Edwards Com accumulated 2,000 shares. Savings Bank Of Hawaii reported 0.04% in Kohl's Corporation (NYSE:KSS). Alliancebernstein Limited Partnership stated it has 0.01% in Kohl's Corporation (NYSE:KSS).
Restructuring Capital Associates Lp, which manages about $1.47 billion and $176.21 million US Long portfolio, decreased its stake in Nuveen Floating Rate Income (JFR) by 42,000 shares to 859,199 shares, valued at $9.36 million in 2018Q1, according to the filing.
More recent Kohl's Corporation (NYSE:KSS) news were published by: Seekingalpha.com which released: “Kohl’s: Harsh Reaction” on May 24, 2018. Also Seekingalpha.com published the news titled: “Kohl’s reverses gain during earnings call” on May 22, 2018. Seekingalpha.com‘s news article titled: “JC Penney’s Turnaround Story Appears Bleak” with publication date: June 15, 2018 was also an interesting one.